Target intelligence / Profile preview

Tetanus toxin (Tetanospasmin) (TeNT)

Target
TeNT
Molecular classification
Bacterial exotoxin, Zinc metalloproteinase, Enzyme, Neurotoxin
01

Overview

Tetanus toxin, also known as tetanospasmin, is a highly potent neurotoxin produced by the vegetative cells of Clostridium tetani [4, 5]. It is the primary virulence factor responsible for tetanus, a life-threatening condition characterized by generalized muscle rigidity and violent spasms [18, 19]. The toxin is synthesized as a single 150 kDa polypeptide chain that is subsequently cleaved into a heavy chain (100 kDa) and a light chain (50 kDa) linked by a disulfide bond [5, 13]. The heavy chain mediates high-affinity binding to gangliosides on motor neurons and facilitates the toxin's retrograde transport to the central nervous system, while the light chain functions as a zinc-dependent metalloproteinase [13, 14]. Once inside inhibitory interneurons, the light chain cleaves vesicle-associated membrane protein 2 (VAMP-2/synaptobrevin), effectively blocking the release of inhibitory neurotransmitters such as GABA and glycine [4, 13]. This blockade results in the characteristic over-excitation of motor neurons and painful muscle contractions [5, 18]. Therapeutic strategies involve the use of tetanus immune globulin (TIG) or monoclonal antibodies like siltartoxatug to neutralize the toxin in the circulation before it can bind to neuronal receptors [1, 12, 16].

Other names
TetanospasminTeTxTetanus neurotoxinSpasmogenic toxinTentoxilysin
02

Mechanism of action

Neutralization of circulating tetanus toxin to prevent its binding to neuronal gangliosides and subsequent internalization; inhibition of the toxin's zinc-metalloproteinase activity which cleaves VAMP-2/synaptobrevin.

03

Biological functions

ProteolysisInhibition of neurotransmitter releaseRetrograde axonal transportVesicle-mediated transport
04

Disease associations

TetanusInfectionNeonatal tetanus
05

Safety considerations

Extreme lethality (LD50 ~2.5 ng/kg)Inability of antibodies to neutralize toxin already bound to or internalized by neuronsRisk of anaphylaxis or serum sickness with animal-derived antitoxinsPotential for respiratory failure due to laryngospasm or chest wall rigidity
06

Interacting drugs

Tetanus immune globulin

3 more in the full profile.

07

Biomarkers

Anti-tetanus antibody titer

Beyond the preview

Go deeper on Tetanus toxin (Tetanospasmin) (TeNT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetanus toxin (Tetanospasmin) (TeNT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call